CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Issue: Health products - Product quality
What to do: Consult your healthcare provider for any health concerns.
Audience: Healthcare, Industry
Recall class: Type III
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|
| Omega Laboratories Limited | Cisatracurium Besylate Injection USP Multidose | DIN 02408813 | Solution | Cisatracurium (Cisatracurium besilate) 2 mg/mL | B5C646A, B5D664A |
| | | | | |
The level of the degradation product Benzaldehyde may be out of specification in the affected lots.